Karl Gaffney
Karl Gaffney
conultant Rheumatologist & Honorary Professor, Norwich
Verified email at nnuh.nhs.uk - Homepage
Cited by
Cited by
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
DM Evans, CCA Spencer, JJ Pointon, Z Su, D Harvey, G Kochan, ...
Nature genetics 43 (8), 761-767, 2011
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis
D Baeten, J Sieper, J Braun, X Baraliakos, M Dougados, P Emery, ...
New England journal of medicine 373 (26), 2534-2548, 2015
Activation of the transcription factor nuclear factor‐κB in human inflamed synovial tissue
R Marok, PG Winyard, A Coumbe, ML Kus, K Gaffney, S Blades, PI Mapp, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1996
Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response.
K Gaffney, J Ledingham, JD Perry
Annals of the rheumatic diseases 54 (5), 379-381, 1995
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
A Cortes, SL Pulit, PJ Leo, JJ Pointon, PC Robinson, MH Weisman, ...
Nature communications 6 (1), 1-8, 2015
Quantification of rheumatoid synovitis by magnetic resonance imaging
K Gaffney, J Cookson, D Blake, A Coumbe, S Blades
Arthritis & Rheumatism: Official Journal of the American College of …, 1995
Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years
AYN Lim, K Gaffney, DGI Scott
Rheumatology 44 (8), 1051-1055, 2005
Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis
A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ...
Arthritis & Rheumatology 71 (2), 258-270, 2019
Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging
K Gaffney, J Cookson, S Blades, A Coumbe, D Blake
Annals of the rheumatic diseases 57 (3), 152-157, 1998
Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers
JL Jorizzo, JL Abernethy, WL White, HC Mangelsdorf, CC Zouboulis, ...
Journal of the American Academy of Dermatology 32 (6), 968-976, 1995
Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled …
A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ...
Arthritis & rheumatology 71 (4), 599-611, 2019
Chronic periaortitis
RN Jois, K Gaffney, T Marshall, DGI Scott
Rheumatology 43 (11), 1441-1446, 2004
BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology
A Keat, N Barkham, A Bhalla, K Gaffney, H Marzo-Ortega, S Paul, ...
Rheumatology 44 (7), 939-947, 2005
~ 1-Proteinase Inhibitor, Elastase Activity, and Lung Disease Severity in Cystic Fibrosis
CM O'Connor, K Gaffney, J Keane, A Southey, N Byrne, S O'Mahoney, ...
American Review of Respiratory Disease 148, 1665-1665, 1993
Recognition of inflammatory back pain and ankylosing spondylitis in primary care
RN Jois, AJ Macgregor, K Gaffney
Rheumatology 47 (9), 1364-1366, 2008
Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis
M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ...
Arthritis & Rheumatology 67 (8), 2011-2019, 2015
Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?
MP Sykes, H Doll, R Sengupta, K Gaffney
Rheumatology 54 (12), 2283-2284, 2015
Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a …
NJ Wiles, DGI Scott, EM Barrett, P Merry, E Arie, K Gaffney, AJ Silman, ...
Annals of the rheumatic diseases 60 (10), 956-961, 2001
Low-dose infliximab treatment for ankylosing spondylitis—clinically-and cost-effective
RN Jois, J Leeder, A Gibb, K Gaffney, A Macgregor, M Somerville, ...
Rheumatology 45 (12), 1566-1569, 2006
Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis
AC Keat, K Gaffney, AK Gilbert, C Harris, J Leeder
Rheumatology 47 (4), 481-483, 2008
The system can't perform the operation now. Try again later.
Articles 1–20